Clinical Trials in Baltimore

Showing 3881-3900 of 11,905 trials

Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients

NCT01838395

A study is designed to assess if BL-8040 in combination with cytarabine (Ara-C) can help controlling the disease in patients with Acute Myeloid Leukemia (AML) that have relapsed or did not respond adequately to previous treatment. The safety of the study drug combination will also be studied.

Acute Myeloid Leukemia

BioLineRx, Ltd.42 participantsStarted Apr 2013

Jacksonville, Florida, United States • Baltimore, Maryland, United States • St Louis, Missouri, United States +7 more locations

COMPLETED< 1 mile

Clinical Evaluation of the i-STAT TBI Test

NCT04171960

The goal of this study is to evaluate the i-STAT TBI test to assist determining the need for a computed tomography (CT) scan in patients with suspected mild traumatic brain injury (TBI). Patients will be asked to provide a blood sample.

Traumatic Brain Injury

Abbott Point of Care1,106 participantsStarted Jul 2020

San Francisco, California, United States • Denver, Colorado, United States • Englewood, Colorado, United States +18 more locations

Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients

Clinical Evaluation of the i-STAT TBI Test

Find Trials by Condition in Baltimore

Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

A Study to Assess the Safety of SAB-176 to Prevent the Flu, Given IM in Healthy Adults Compared With Placebo

Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

The PREDICT Registry:

Viz HCM (ECG Assist) Utilization Workflow Pilot

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

Air Optix® Night and Day® Aqua Continuous Wear

Randomized Controlled Trial for Vestibular Treatment in Concussion

An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen)

Long-term Safety of Lumacaftor/Ivacaftor in Participants With Cystic Fibrosis Who Are Homozygous for F508del and 12 to <24 Months of Age at Treatment Initiation

A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients

Target Controlled Infusion Using Propofol and Remifentanil for Moderate Sedation in Dentistry